Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progression.

Rafaeva M, Jensen ARD, Horton ER, Zornhagen KW, Strøbech JE, Fleischhauer L, Mayorca-Guiliani AE, Nielsen SR, Grønseth DS, Kuś F, Schoof EM, Arnes L, Koch M, Clausen-Schaumann H, Izzi V, Reuten R, Erler JT

Open source

DOI: 10.3389/fimmu.2023.1154528
Published: 2023
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2023.1154528,
  title = {Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progression.},
  author = {Rafaeva M and Jensen ARD and Horton ER and Zornhagen KW and Strøbech JE and Fleischhauer L and Mayorca-Guiliani AE and Nielsen SR and Grønseth DS and Kuś F and Schoof EM and Arnes L and Koch M and Clausen-Schaumann H and Izzi V and Reuten R and Erler JT},
  year = {2023},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2023.1154528},
  url = {https://doi.org/10.3389/fimmu.2023.1154528}
}

RIS

TY  - JOUR
TI  - Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progression.
AU  - Rafaeva M
AU  - Jensen ARD
AU  - Horton ER
AU  - Zornhagen KW
AU  - Strøbech JE
AU  - Fleischhauer L
AU  - Mayorca-Guiliani AE
AU  - Nielsen SR
AU  - Grønseth DS
AU  - Kuś F
AU  - Schoof EM
AU  - Arnes L
AU  - Koch M
AU  - Clausen-Schaumann H
AU  - Izzi V
AU  - Reuten R
AU  - Erler JT
PY  - 2023
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2023.1154528
UR  - https://doi.org/10.3389/fimmu.2023.1154528
ER  -

APA

M, R., ARD, J., ER, H., KW, Z., JE, S., L, F., AE, M., SR, N., DS, G., F, K., EM, S., L, A., M, K., H, C., V, I., R, R., & JT, E. (2023). Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progression.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2023.1154528

Source records

pubmed · retrieved 2026-09-25T22:44:07.981Z